Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
EBS
— Emergent BioSolutions Inc.
NYSE
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 1, 2026
REVENUE
$156.1M
+5.0%
NET MARGIN
4.4%
+41.1 PTS
EPS
$0.13
+112.5%
FREE CASH FLOW
-$36.2M
-149.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →